ISM-6331

N/A

Report date: 2024/12/31 11:25:47
NME

Base Information

Drug NameISM-6331
Drug Alias NameISM6331ISM-6331
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscriptional enhancer factor inhibitors
TargetsTranscriptional enhancer factor
Therapy Area/IndicationsSolid tumoursMesothelioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInsilico Medicine Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInsilico Medicine LtdInSilico Medicine Hong Kong Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursMesothelioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A